Product correctly added to cart.

discount label
BI 425809
View 3D

Biosynth logo

BI 425809

CAS: 1421936-85-7

Ref. 3D-FM180750

1mg
711.00 €
2mg
1,021.00 €
5mg
1,594.00 €
10mg
2,296.00 €
25mg
5,101.00 €
Estimated delivery in United States, on Monday 24 Feb 2025

Product Information

Name:
BI 425809
Description:

BI 425809 is a drug that belongs to the class of selective serotonin reuptake inhibitors (SSRIs) and has been shown in clinical studies to be effective in the treatment of depression. The safety profile of BI 425809 has been established in clinical trials with healthy Chinese subjects, where it was found that the drug had no harmful effects at doses up to 400 mg/day. The concentration-time curve for BI 425809 showed an interactive response with food intake, which may indicate a need for dosage adjustment when taken with food. Pharmacokinetic properties have been evaluated in healthy Chinese subjects, showing that oral absorption is rapid and complete; elimination is mainly by hepatic metabolism; and elimination half-life is approximately 12 hours. BI 425809 has a low potential for abuse as it does not bind to dopamine receptors or produce any rewarding effects.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FM180750 BI 425809

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".